These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6079865)

  • 1. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. II. Active immunization of mammary-tumor-agent-free mice.
    Suit HD; Silobrcic V
    J Natl Cancer Inst; 1967 Dec; 39(6):1121-8. PubMed ID: 6079865
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-specific antigen(s) in a spontaneous mammary carcinoma of C3H mice. I. Quantitative cell transplants into mammary-tumor-agent-positive and -free mice.
    Silobrcic V; Suit HD
    J Natl Cancer Inst; 1967 Dec; 39(6):1113-9. PubMed ID: 6079864
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced immune reactivity to hepatoma 22a cells in MTV-infected compared with MTV-free C3H mice.
    Lavrovsky VA; Viksler VK
    Immunology; 1981 Dec; 44(4):671-6. PubMed ID: 6274791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF; Edwards AJ; Hurd CM; Sumner MR
    J Natl Cancer Inst; 1971 Aug; 47(2):321-7. PubMed ID: 4934422
    [No Abstract]   [Full Text] [Related]  

  • 5. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies on tumor-specific immunity by using C3H mammary cancer-A cells. 3. Specificity of aggregation of sensitized lymph-node cells on target cells.
    Satoh K
    Acta Med Okayama (1952); 1967 Apr; 21(2):67-78. PubMed ID: 4229455
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic interactions between isologous or F1 hybrid hosts and spontaneous mammary tumors in CBA-Bln mice.
    Müller M
    Cancer Res; 1967 Dec; 27(12):2272-9. PubMed ID: 4866761
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired immunological tolerance and carcinogenesis by the mammary tumor virus. II. Immune responses influencing growth of spontaneous mammary adenocarcinomas.
    Morton DL; Goldman L; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):321-9. PubMed ID: 4303884
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation.
    Tanino T
    Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation between tumor-specific systemic and in situ immunity as manifested by the delayed hypersensitivity response.
    Radov LA; Haskill JS; Korn JH; Fett JW
    J Natl Cancer Inst; 1979 Jan; 62(1):103-8. PubMed ID: 281564
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. II. Search for a common antigen in some organs and spontaneous mammary carcinomas.
    Rejthar A; Wotke J
    Folia Biol (Krakow); 1973; 21(1):52-7. PubMed ID: 4693119
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 14. Demonstration of tumor-specific immunity against antigens unrelated to the mammary tumor virus in spontaneous mammary adenocarcinomas.
    Morton DL; Miller GF; Wood DA
    J Natl Cancer Inst; 1969 Feb; 42(2):289-301. PubMed ID: 4303881
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor specificity, serum inhibition, and influence of regional lymph nodes on cytotoxic macrophages from cultured bone marrow.
    Fisher B; Hanlon JT; Linta J; Saffer E
    Cancer Res; 1977 Oct; 37(10):3628-33. PubMed ID: 908011
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism.
    Tokuzen R; Nakahara W
    Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465
    [No Abstract]   [Full Text] [Related]  

  • 19. [Induction of specific resistance in Swiss mice using x-irradiated cells of the ATPC+ ascitic tumor].
    Marconi P; Fimiani E; Bistoni F; Latini A
    Boll Soc Ital Biol Sper; 1973 May; 49(10):529-33. PubMed ID: 4132961
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.